AMRX - Amneal Pharmaceuticals Non-GAAP EPS of $0.19 beats by $0.06 revenue of $620M beats by $15.47M
2023-11-07 06:04:37 ET
More on Amneal Pharmaceuticals
- Amneal Pharmaceuticals: A High-Wire Act Between Growth And Debt
- Amneal Pharmaceuticals raises its FY outlook
- Amneal to reorganize and simplify corporate structure
- Seeking Alpha’s Quant Rating on Amneal Pharmaceuticals
- Historical earnings data for Amneal Pharmaceuticals
For further details see:
Amneal Pharmaceuticals Non-GAAP EPS of $0.19 beats by $0.06, revenue of $620M beats by $15.47M